Efficacy and safety of luspatercept with or without erythropoiesis-stimulating agent in patients with myelodysplastic neoplasms with ring sideroblasts: A multicentre real-life study by the GFM.

ABSTRACT:

SUBMITTER: D'Aveni M 

PROVIDER: S-EPMC12436241 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature